Exploring novel inflammatory mechanisms in heart failure (HFpEF and HFrEF) – the role of canonical and non-canonical inflammasome activation and pyroptosis in heart failure, the role of the bone marrow and CHIP in heart failure development
Studying the interplay between metabolic diseases (hypercholesterolemia, steatohepatitis) and cardiac dysfunction
Cardio-oncology and onco-cardiology projects: elucidating the mechanisms of immune-checkpoint induced cardiotoxicity
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.
National VAT number: 26307383-2-06 EU VAT number: HU26307383